Louis Kayitalire - 02 Nov 2021 Form 4 Insider Report for F-star Therapeutics, Inc.

Role
Chief Medical Officer
Signature
/s/ Darlene Deptula-Hicks, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
02 Nov 2021
Net transactions value
-$437
Form type
4
Filing time
04 Nov 2021, 21:34:12 UTC
Previous filing
06 Oct 2021
Next filing
11 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FSTX Common Stock Sale $266 -39 -0.07% $6.81 54,280 02 Nov 2021 Direct F1, F2
transaction FSTX Common Stock Sale $171 -25 -0.05% $6.85 54,255 02 Nov 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to the 10b5-1 Plan entered into by the Reporting Person.
F2 Includes 45,443 restricted stock units.